You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 16, April 22/29, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Cardiovascular Interventions, Other
 •Cardiovascular System
 •Prognosis/ Outcomes
 •Congestive Heart Failure/ Cardiomyopathy
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Outcomes of Medicare Beneficiaries With Ventricular Assist Devices

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study of long-term outcomes and costs of ventricular assist devices by Dr Hernandez and colleagues1 provided some interesting data, but because of the large amount of progress in this field over the past 2 years, it is of mostly historical value for comparisons with current outcomes with these devices. Also, the observations are too broad because of the inclusion of patients with multiple device indications, various devices used for diverse indications, and unknown indications for readmissions.

Mechanical circulatory support is moving rapidly away from pulsatile design pumps (the exclusive type reported by Hernandez et al) to a new generation of nonpulsatile, continuous flow design.2 In one study, using the new design as a bridge to a transplantation resulted in 68% 1-year actuarial survival; at 3 months there was a 73% increase in patient-assessed quality of life by Kansas City Cardiomyopathy Questionnaire at 3 months (from 33 . . . [Full Text of this Article]

Leslie W. Miller, MD
leslie.w.miller@medstar.net
Department of Medicine
Washington Hospital Center
Washington, DC



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare Beneficiaries
Adrian F. Hernandez, Alisa M. Shea, Carmelo A. Milano, Joseph G. Rogers, Bradley G. Hammill, Christopher M. O’Connor, Kevin A. Schulman, Eric D. Peterson, and Lesley H. Curtis
JAMA. 2008;300(20):2398-2406.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Outcomes of Medicare Beneficiaries With Ventricular Assist Devices
Daniel B. Sims, Yoshifumi Naka, and Ulrich P. Jorde
JAMA. 2009;301(16):1657.
EXTRACT | FULL TEXT  

Outcomes of Medicare Beneficiaries With Ventricular Assist Devices
Mark S. Slaughter
JAMA. 2009;301(16):1657-1658.
EXTRACT | FULL TEXT  

Outcomes of Medicare Beneficiaries With Ventricular Assist Devices—Reply
Adrian F. Hernandez, Bradley G. Hammill, and Lesley H. Curtis
JAMA. 2009;301(16):1658.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.